Immediate release dosage forms of sodium oxybate
US8771735B2 · kind B2 · utility
59Cited by
23References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2008 |
| Grant date | Jul 8, 2014 |
| Priority date | — |
| Expiry date | Mar 20, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a pharmaceutical composition, presented as a solid unit dosage form adapted for oral administration of sodium oxybate. The preferred unit dosage form is a tablet comprising a relatively high weight-percentage of sodium oxybate, in combination with a relatively small weight-percentage of total excipients. This permits the tablets to contain/deliver a pharmaceutically effective amount, e.g., about 0.5-1.5 g of sodium oxybate in each tablet with a delivery profile similar to that of the liquid form. The tablets are bioequivalent to the liquid form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.